Comparison of diagnostic and prognostic utility of lactate and procalcitonin for sepsis in adult cancer patients presenting to emergency department with systemic inflammatory response syndrome


Keçe E., Yaka E., Yılmaz S., Doğan N. Ö., Alyeşil C., Pekdemir M.

TURKISH JOURNAL OF EMERGENCY MEDICINE, cilt.16, sa.1, ss.1-7, 2016 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.tjem.2016.02.003
  • Dergi Adı: TURKISH JOURNAL OF EMERGENCY MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier
  • Sayfa Sayıları: ss.1-7
  • Anahtar Kelimeler: Cancer, Sepsis, Lactate, Procalcitonin, C-REACTIVE PROTEIN, CRITICALLY-ILL PATIENTS, MORTALITY, BACTEREMIA, MARKER, EPIDEMIOLOGY, PREDICTION, INFECTION, BIOMARKER, ACCURACY
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Objectives: Differentiating sepsis from other noninfectious causes of systemic inflammatory response syndrome (SIRS) in cancer patients is often challenging. Although lactate and procalcitonin have been studied extensively regarding sepsis management, little is known about their utility in cancer patients. This study aimed to compare the diagnostic and prognostic utility of lactate and procalcitonin for sepsis in cancer patients.